Omega-3 fatty acids modulate collagen signaling in human platelets.

[1]  F. Del Porto,et al.  Association between fibrinogen plasma levels and platelet counts in an outpatient population and in patients with coronary heart disease , 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[2]  V. Deneer,et al.  Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. , 2010, JAMA.

[3]  S. Koyasu,et al.  Non-redundant Roles of Phosphoinositide 3-Kinase Isoforms α and β in Glycoprotein VI-induced Platelet Signaling and Thrombus Formation* , 2009, The Journal of Biological Chemistry.

[4]  Y. Ozaki,et al.  Novel synthetic collagen fibers, poly(PHG), stimulate platelet aggregation through glycoprotein VI , 2009, FEBS letters.

[5]  W. Harris,et al.  Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults , 2008, Current atherosclerosis reports.

[6]  J. Schwab,et al.  Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. , 2008, Blood.

[7]  J. Akkerman,et al.  Role of membrane cholesterol in platelet calcium signalling in response to VWF and collagen under stasis and flow , 2008, Thrombosis and Haemostasis.

[8]  K. Harris,et al.  Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects , 2008, Thrombosis and Haemostasis.

[9]  W. Harris.  Expert opinion: omega-3 fatty acids and bleeding-cause for concern? , 2007, The American journal of cardiology.

[10]  S. Kunapuli,et al.  Glycoprotein VI agonists have distinct dependences on the lipid raft environment , 2007, Journal of thrombosis and haemostasis : JTH.

[11]  A. Sastre,et al.  Effects of omega-3 fatty acids on heart rate in cardiac transplant recipients. , 2006, The American journal of cardiology.

[12]  C. Terry,et al.  (N-3) long-chain polyunsaturated fatty acids prolong survival following myocardial infarction in rats. , 2006, The Journal of nutrition.

[13]  B. Furie,et al.  Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. , 2006, Blood.

[14]  M. V. van Zandvoort,et al.  The Glycoprotein VI-Phospholipase C&ggr;2 Signaling Pathway Controls Thrombus Formation Induced by Collagen and Tissue Factor In Vitro and In Vivo , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[15]  J. Cazenave,et al.  Importance of Platelet Phospholipase Cγ2 Signaling in Arterial Thrombosis as a Function of Lesion Severity , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[16]  Junmei Chen,et al.  Interactions of Platelets with Subendothelium and Endothelium , 2005, Microcirculation.

[17]  J. Lupton,et al.  n‐3 PUFA Alter caveolae lipid composition and resident protein localization in mouse colon , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  S. Watson,et al.  c‐Cbl negatively regulates platelet activation by glycoprotein VI , 2003, Journal of thrombosis and haemostasis : JTH.

[19]  R. Polanowska-Grabowska,et al.  Platelet Adhesion to Collagen and Collagen-Related Peptide Under Flow: Roles of the &agr;2&bgr;1 Integrin, GPVI, and Src Tyrosine Kinases , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[20]  J. Lovegrove,et al.  Quercetin inhibits collagen‐stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway , 2003, Journal of thrombosis and haemostasis : JTH.

[21]  S. Watson,et al.  Integrin α2β1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCγ2 , 2003, The Journal of cell biology.

[22]  L. Parise,et al.  Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets. , 2003, Blood.

[23]  B. Furie,et al.  Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse , 2002, Nature Medicine.

[24]  Y. Liu,et al.  Lipid Rafts Orchestrate Signaling by the Platelet Receptor Glycoprotein VI* , 2002, The Journal of Biological Chemistry.

[25]  J. Manson,et al.  Blood levels of long-chain n-3 fatty acids and the risk of sudden death. , 2002, The New England journal of medicine.

[26]  William L. Smith,et al.  Structure of Eicosapentaenoic and Linoleic Acids in the Cyclooxygenase Site of Prostaglandin Endoperoxide H Synthase-1* , 2001, The Journal of Biological Chemistry.

[27]  R. Mensink,et al.  Effects of dietary n-3 polyunsaturated fatty acids from plant and marine origin on platelet aggregation in healthy elderly subjects , 1999, British Journal of Nutrition.

[28]  Roberto Marchioli,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .

[29]  T. Raghunathan,et al.  Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. , 1995, JAMA.

[30]  G. Billman,et al.  Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Fonlupt,et al.  Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function. , 1990, The Journal of biological chemistry.

[32]  M. Steiner,et al.  Fish oil: a potent inhibitor of platelet adhesiveness. , 1990, Blood.

[33]  W. Harris,et al.  The combined effects of N-3 fatty acids and aspirin on hemostatic parameters in man. , 1990, Thrombosis research.

[34]  J. Kinsella,et al.  Ca2+-Mg2+ ATPase of mouse cardiac sarcoplasmic reticulum is affected by membrane n-6 and n-3 polyunsaturated fatty acid content. , 1989, The Journal of nutrition.

[35]  G. FitzGerald,et al.  In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. , 1986, The New England journal of medicine.

[36]  M. Lagarde,et al.  Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. , 1984, Thrombosis research.

[37]  J. Vane,et al.  EICOSAPENTAENOIC ACID AND PREVENTION OF THROMBOSIS AND ATHEROSCLEROSIS? , 1978, The Lancet.

[38]  U. Essers,et al.  CANCER RESEARCH: SOME FORWARD STEPS. , 1965, Lancet.